title: Antithrombotic therapy in patients undergoing coronary angioplasty.
authors.affiliation: Interventional Cardiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA. jjpopma@bics.bwh.harvard.edu
authors.forename: J J
authors.initials: JJ
authors.lastname: Popma
authors.forename: J
authors.initials: J
authors.lastname: Weitz
authors.forename: J A
authors.initials: JA
authors.lastname: Bittl
authors.forename: E M
authors.initials: EM
authors.lastname: Ohman
authors.forename: R E
authors.initials: RE
authors.lastname: Kuntz
authors.forename: A J
authors.initials: AJ
authors.lastname: Lansky
authors.forename: S B
authors.initials: SB
authors.lastname: King
mesh_terms: D000077284:Abciximab; D015906:Angioplasty, Balloon, Coronary / Q000009:adverse effects; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D000925:Anticoagulants / Q000627:therapeutic use*; D001241:Aspirin / Q000627:therapeutic use; D003327:Coronary Disease / Q000628:therapy; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D007140:Immunoglobulin Fab Fragments / Q000627:therapeutic use; D019039:Platelet Glycoprotein GPIIb-IIIa Complex / Q000037:antagonists & inhibitors; D012008:Recurrence; D015607:Stents
chemical_list: D000911:Antibodies, Monoclonal; D000925:Anticoagulants; D005343:Fibrinolytic Agents; D007140:Immunoglobulin Fab Fragments; D019039:Platelet Glycoprotein GPIIb-IIIa Complex; D006493:Heparin; D001241:Aspirin; D000077284:Abciximab